The Latest on Changes in CIRM's Biotech Loan Program
CIRM today reported another change in what is to be expected concerning alterations in the $500 million biotech loan program at tomorrow's and Thursday's meetings of its board of directors.
In an email, Don Gibbons, CIRM's chief communications officer, said,
“There is a bit of change again in the agenda. We decided that we needed the loan term guidelines…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.